M2 macrophages reduce the effect of gefitinib by activating AKT/mTOR in gefitinib‐resistant cell lines HCC827/GR

BACKGROUND: The biological behavior of cells change after they develop drug resistance, and the degree of resistance will be affected by the tumor microenvironment. Here, we aimed to explore the changes in the biological behavior of tumors and to observe the differences in the release of cytokines a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Fengqi, Liu, Ni, Ma, Xinchun, Qin, Jing, Liu, Yanguo, Wang, Xiuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606002/
https://www.ncbi.nlm.nih.gov/pubmed/32956565
http://dx.doi.org/10.1111/1759-7714.13670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606002/
https://www.ncbi.nlm.nih.gov/pubmed/32956565
http://dx.doi.org/10.1111/1759-7714.13670

Ejemplares similares